Clearside’s CLS-AX shows promise in treatment of wet age-related macular degeneration
Patients with wet age-related macular degeneration receiving CLS-AX achieved stable visual acuity, and retinal thickness for up to six months. ...
Patients with wet age-related macular degeneration receiving CLS-AX achieved stable visual acuity, and retinal thickness for up to six months. ...
1. In a retrospective study examining 50,000 optical coherence tomography (OCT) images from a large database, thicknesses of several different ...
1. A model combining artificial intelligence-enabled analysis of retinal vascular images from a large database with several traditional risk factors ...
1. In a retrospective study of about 30,000 patients, the incidence of post-vitrectomy endophthalmitis increased significantly from 0.11% to 0.21% ...
1. Intravitreal bevacizumab injections for central serous chorioretinopathy show long-term outcomes of complete remission in 90% of patients, 2. Thick ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.